| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8243480 | International Journal of Radiation Oncology*Biology*Physics | 2007 | 8 Pages |
Abstract
Conclusions: Subcutaneous amifostine provides a well-tolerated yet simpler alternative to i.v. amifostine for reducing acute xerostomia in head-and-neck cancer patients.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Pramila Rani M.D., Mitchell M.D., David I. M.D., David M. M.D., William H. M.D., David H. M.D., Prakash B. M.D., Noel C. M.D., Anthony M.D., Walter J. M.D.,